or Try an Advanced Search...

    ETF Components for LABD - Direxion Daily S&P Biotech Bear 3X Shares


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    EXEL C -0.86 1.91
    BMRN D -1.51 1.89
    BLUE F -0.95 1.87
    VRTX B -0.74 1.84
    SAGE F -1.85 1.80
    UTHR B -1.90 1.78
    REGN B -1.97 1.77
    AMGN B -0.45 1.75
    ALNY A 0.43 1.73
    EXAS F 0.05 1.73
    ABBV C -1.28 1.72
    ACAD D -1.58 1.68
    SRPT C -0.71 1.66
    BIIB C -1.84 1.65
    IONS B 1.02 1.64
    GILD C -2.65 1.64
    NBIX C 0.54 1.62
    BPMC B -1.21 1.61
    INCY C -2.30 1.51
    RARE F -1.83 1.49
    MRNA D -0.96 1.47
    LGND B -2.46 1.46
    ARWR C -0.59 1.45
    BHVN F -1.11 1.42
    PTCT D 2.01 1.40
    FOLD F -0.41 1.38
    AGIO C -0.07 1.37
    APLS F 1.23 1.24
    ALKS D 0.17 1.21
    MYGN B 0.77 1.08
    NTRA B 0.85 1.08
    IOVA F -4.40 1.07
    FGEN F -7.00 1.05
    RGNX F 0.65 1.05
    DCPH A 0.00 1.01
    CHRS F 0.00 0.99
    EBS B 0.67 0.96
    CDNA B -0.07 0.93
    HRTX C 1.09 0.84
    INSM C -3.88 0.81
    KPTI F 3.53 0.79
    ESPR C 0.85 0.79
    ALLK F -9.59 0.76
    IRWD F -1.77 0.75
    VCYT C 0.99 0.72
    HALO B 1.38 0.71
    FATE F -1.86 0.67
    EDIT F 2.64 0.66
    PBYI F -2.58 0.65
    MDGL C 0.00 0.59
    TGTX B 2.62 0.55
    ADVM F 4.24 0.55
    ALLO F -3.70 0.54
    CPRX D -3.10 0.53
    ANAB B 4.01 0.53
    XNCR F 1.92 0.49
    SGMO F 0.59 0.48
    ENTA C -2.30 0.47
    EGRX C 5.16 0.42
    GTHX F 4.90 0.42
    ATRA F 2.53 0.41
    VKTX D -2.08 0.38
    ANIK D -2.57 0.37
    VNDA C 1.71 0.35
    OPK F 0.41 0.35
    VCEL D -0.36 0.34
    TVTX C -1.85 0.33
    KOD F -1.79 0.29
    BBIO D 0.36 0.29
    NTLA F 3.61 0.29
    PGEN C -1.34 0.29
    DNLI C -2.02 0.28
    KRYS C -0.03 0.28
    GOSS C 7.31 0.27
    VYGR F 1.84 0.26
    MGNX F 2.44 0.25
    ALEC F 1.61 0.25
    CYTK D -0.80 0.25
    DVAX F -0.54 0.24
    YMAB D 0.09 0.24

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Biotechnology Medicine Cancer Life Sciences Clinical Development Biology Chemical Compounds Inflammation Clinical Medicine Disease Immune System Immunology S&P 500 Cholesterol Genetics Infectious Diseases Monoclonal Antibody Nasdaq 100 Organ Systems
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Diagnostics & Research

    Recent News for Direxion Daily S&P Biotech Bear 3X Shares & its Holdings

    Date Stock Title
    Jul 3 ATRA Atara Biotherapeutics To Participate at the Stifel Virtual Cell Therapy Forum
    Jul 3 BLUE bluebird bio Reports Inducement Grant to CFO James Sterling Under Nasdaq Listing Rule 5635(c)(4)
    Jul 3 CYTK Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
    Jul 3 INSM Insmed sees brensocatib NDA for bronchiectasis in Q4
    Jul 3 ABBV AbbVie Q2 IPR&D expenses to lower EPS by $0.52
    Jul 3 ATRA Atara Biotherapeutics: An Underestimated Contender In Autoimmune Diseases CAR-T Cell Therapy
    Jul 3 VKTX S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 AMGN S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 MRNA GSK To Spend Up to $1.56B for Rights to Potential COVID-19, Flu Vaccines
    Jul 3 BIIB Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
    Jul 3 INSM More endpoints met in Insmed’s Phase III brensocatib trial
    Jul 3 BIIB Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
    Jul 3 MRNA GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
    Jul 3 INSM Insmed Presenting More Positive Data for Prospective Drug Treatment for Bronchiectasis This Week
    Jul 3 EBS Emergent scores US medical countermeasure contracts worth over $250m
    Jul 3 SRPT 1 Soaring Growth Stock to Buy and Hold for 10 Years
    Jul 3 MRNA Moderna (MRNA) Secures BARDA Funding for Bird Flu Vaccine
    Jul 3 SRPT Best Momentum Stocks to Buy for July 3rd
    Jul 3 ABBV Company News for Jul 3, 2024
    Jul 3 AMGN Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
    The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the performance of the S&P Biotechnology Select Industry Index. The index is provided by Standard & Poor's and includes domestic companies from the biotechnology industry. The fund normally creates short positions by investing at least 80% of its assets in: swap agreements; options on securities and indices; forward contracts; short positions; reverse repurchase agreements; ETFs; and other financial instruments that, in combination, provide inverse leveraged and unleveraged exposure to the S&P Biotechnology Select Industry Index ("index"). It is non-diversified.
    Exchange Traded Fund ETF Exchange Traded Funds Biotechnology Leveraged ETF Ultra ETF S&P 500 Index CBOE Inverse ETF Bear Market ETF Repurchase Agreement Financial Regulation Forward Contract
    Back to the Main LABD Page...